The Need for Navigators Across the Advanced or Metastatic NSCLC Journey
This workmat outlines how patient and tissue navigators may be able to help solve and prevent challenges commonly faced during the molecular testing process in non-small cell lung cancer (NSCLC).
Date of Last Review: March 20, 2025
Please rate your satisfaction with the content on the following statements:
Very Dissatisfied
Dissatisfied
Neutral
Satisfied
Very Satisfied
Credibility of information
Relevance of the information to my needs
Confidence to implement the learnings in my clinical practice
Please rate your satisfaction with the content on the following statements:
Credibility of information
Relevance of the information to my needs
Confidence to implement the learnings in my clinical practice